Called Neffy, it offers a needle-free alternative to the EpiPen used by those at risk of potentially fatal anaphylaxis to inject themselves with adrenaline.
Alnylam Pharmaceuticals Inc. ALNY) on Thursday reported third-quarter net income of $251.1 million, after reporting a loss in the same period a year earlier.
CREATE Medicines, Inc. (formerly Myeloid Therapeutics) today announced new preclinical data for RetroT, the company's fully ...
Attima Hadlari, a longtime board member of Nunavut Tunngavik Inc. (NTI), drum dancer and founding president of Red Fish Arts ...
Waterloo Region staff recommend LRT extension from Fairway Station to Ainslie Street in Cambridge, aiming for federal and ...
Akamai Technologies, Inc. today launched Akamai Inference Cloud, a platform that redefines where and how AI is used by expanding inference from core data centers to the edge of the ...
The Business Courier will reveal the Power 25: Growth Champions in the print edition Nov. 14. The Business Courier will ...
A year after Boston's inclusionary zoning policy was made more aggressive, developers and politicians have criticized it for ...
Work on an immense incinerator in Wisbech, Cambs is due to start in just days and locals are dreading the ear-splitting noise ...
READING - The Reading Select Board voted unanimously Tuesday night to support a Local Initiative Program application for ...
Cambridge businesses will have to pay commercial tax bills on average 22% higher this fiscal year, a dramatic increase that ...
Ontario Land Tribunal after city staff error, facing opposition for density and height exemptions, impacting heritage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback